Gegenwärtiger Stand der adjuvanten Chemotherapie des Mammakarzinoms

  • C. G. Schmidt
Conference paper

Zusammenfassung

Die adjuvante Chemotherapie stellt die postoperativ vorgenommene Applikation von Zytostatika bei solchen Tumoren dar, die trotz lokaler Operabilität häufig metastasieren. Die adjuvante Chemotherapie geht nach operativer Entfernung eines Tumors im Gesunden grundsätzlich von der Annahme aus, mögliche okkulte Metastasen vor ihrer Manifestation zu eliminieren. Auf diese Weise soll das Lokalrezidiv bzw. die Fernmetastasierung verhindert und die definitive Heilungsrate verbessert werden [1].

This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Schmidt CG, Seeber S (1975) Neue Perspektiven für eine adjuvante Chemotherapie bei soliden Tumoren. Dtsch Med Wochenschr 100:2342–2348.PubMedCrossRefGoogle Scholar
  2. 2.
    Brunner KW (1981) Nutzen und Gefahren der adjuvanten Chemotherapie und Bestrahlung zur Metastasenprophylaxe. Internist (Berlin) 22:62–67.Google Scholar
  3. 3.
    Fisher B, Slack NH, Bross IDJ (1969) Cancer of the breast: size of neoplasm and prognosis. Cancer 24:1071–1080.PubMedCrossRefGoogle Scholar
  4. 4.
    Fisher B (1977) Biological and clinical considerations regarding the use of surgery and chemotherapy in the treatment of primary breast cancer. Cancer 40:574–587.PubMedCrossRefGoogle Scholar
  5. 5.
    Valagussa P, Bonadonna G, Veronesi U (1978) Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients. Cancer 41:1170–1178.PubMedCrossRefGoogle Scholar
  6. 6.
    Nissen-Meyer R (1979) One short chemotherapy course in primary breast cancer: 12-year follow-up in series 1 of the Scandinavian Adjuvant Chemotherapy Study Group. In: Jones SE, Salmon SE (eds) Adjuvant therapy of cancer, vol 2. Proceedings of the Second International Conference, Tucson, Ariz., Mar. 28–31, 1979. Grune & Stratton, New York London Toronto Sydney San Francisco, pp 207-213.Google Scholar
  7. 7.
    Nissen-Meyer R, Kjellgren K, Malmio K, Mansson R, Norin T (1978) Surgical adjuvant chemotherapy. Results with one short course with cyclophosphamide after mastectomy for breast cancer. Cancer 41:2088–2098.PubMedCrossRefGoogle Scholar
  8. 8.
    Fisher B, Redmond C (1979) Breast cancer studies on the National Surgical Adjuvant Breast and Colon Project (NSABP). In: Jones SE, Salmon SE (eds) Adjuvant therapy of cancer, vol 2. Proceedings of the 2nd International Conference, Tucson, Ariz., Mar. 21–31, 1979. Grune & Stratton, New York London Toronto Sydney San Francisco, pp 215–226.Google Scholar
  9. 9.
    Bonadonna G, Brusamolino E, Valagussa P, Rossi A, Brugnatelli L, Brambilla C, De Lena M, Tancini G, Bajetta E, Musumeci R, Veronesi U (1976) Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 294:405–410.PubMedCrossRefGoogle Scholar
  10. 10.
    Bonadonna G, Rossi A, Valagussa P, Banfi A, Veronesi U (1977) The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance. Cancer 39:2904–2915.PubMedCrossRefGoogle Scholar
  11. 11.
    Bonadonna G, Valagussa P, Rossi A, Tancini G, Bajetta E, Marchini S, Veronesi U (1979) CMF adjuvant chemotherapy in operable breast cancer. In: Jones SE, Salmon SE (eds) Adjuvant therapy of cancer, vol 2. Proceedings of the 2nd International Conference, Tucson, Ariz., Mar. 28–31, 1979. Grune & Stratton, New York London Toronto Sydney San Francisco, pp 227-235.Google Scholar
  12. 12.
    Bonadonna G, Valagussa P, Rossi A, Zucali R, Tancini G, Bajetta E, Brambilla C, De Lena M, Di Fronzo G, Banfi A, Rilke F, Veronesi U (1978) Are surgical adjuvant trials altering the course of breast cancer? Semin Oncol 5:450–464.PubMedGoogle Scholar
  13. 13.
    Bonadonna G, Rossi A, Tancini G, Bajetta E, Valagussa P (1979) CMF adjuvant chemotherapy in operable breast cancer: 4-year results. In: Second breast cancer working conference — Experimental and clinical aspects. European Organization for Research on Treatment of Cancer, Breast Cancer Cooperative Group, Copenhagen, Denmark, May 31–June 2, 1979; Abstracts, p 51.Google Scholar

Copyright information

© Springer-Verlag, Berlin Heidelberg 1984

Authors and Affiliations

  • C. G. Schmidt

There are no affiliations available

Personalised recommendations